File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

TitleReport from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024
Authors
Lambach, PhilippSilal, SheetalSbarra, Alyssa NCrowcroft, Natasha SFrey, KurtFerrari, MattVynnycky, EmiliaMetcalf, C Jessica EWinter, Amy KZimmerman, LauraKoh, MitsukiSheel, MeruKim, Sun-YoungMunywoki, Patrick KPortnoy, AllisonAggarwal, RakeshFarooqui, Habib HasanFlasche, StefanHogan, Alexandra BLeung, KathyMoss, William JWang, Xuan-Yi
KeywordsCongenital rubella syndrome
IVIR-AC
RCV
Rubella
Issue Date13-Sep-2024
PublisherElsevier
Citation
Vaccine, 2024, v. 42, n. 26 How to Cite?
DOI: http://dx.doi.org/10.1016/j.vaccine.2024.126307
Abstract

The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June – 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.


Persistent Identifierhttp://hdl.handle.net/10722/355819
ISSN
0264-410X
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.342
ISI Accession Number ID
WOS:001407194500001

 

DC FieldValueLanguage
dc.contributor.authorLambach, Philipp-
dc.contributor.authorSilal, Sheetal-
dc.contributor.authorSbarra, Alyssa N-
dc.contributor.authorCrowcroft, Natasha S-
dc.contributor.authorFrey, Kurt-
dc.contributor.authorFerrari, Matt-
dc.contributor.authorVynnycky, Emilia-
dc.contributor.authorMetcalf, C Jessica E-
dc.contributor.authorWinter, Amy K-
dc.contributor.authorZimmerman, Laura-
dc.contributor.authorKoh, Mitsuki-
dc.contributor.authorSheel, Meru-
dc.contributor.authorKim, Sun-Young-
dc.contributor.authorMunywoki, Patrick K-
dc.contributor.authorPortnoy, Allison-
dc.contributor.authorAggarwal, Rakesh-
dc.contributor.authorFarooqui, Habib Hasan-
dc.contributor.authorFlasche, Stefan-
dc.contributor.authorHogan, Alexandra B-
dc.contributor.authorLeung, Kathy-
dc.contributor.authorMoss, William J-
dc.contributor.authorWang, Xuan-Yi-
dc.date.accessioned2025-05-17T00:35:17Z-
dc.date.available2025-05-17T00:35:17Z-
dc.date.issued2024-09-13-
dc.identifier.citationVaccine, 2024, v. 42, n. 26-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10722/355819-
dc.description.abstract<p>The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June – 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.<br></p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofVaccine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCongenital rubella syndrome-
dc.subjectIVIR-AC-
dc.subjectRCV-
dc.subjectRubella-
dc.titleReport from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024-
dc.typeArticle-
dc.identifier.doi10.1016/j.vaccine.2024.126307-
dc.identifier.scopuseid_2-s2.0-85203624733-
dc.identifier.volume42-
dc.identifier.issue26-
dc.identifier.eissn1873-2518-
dc.identifier.isiWOS:001407194500001-
dc.identifier.issnl0264-410X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats